Archive - Long COVID Research Breakdown

How federal research continues failing people with myalgic encephalomyelitis, part I

The long and twisted history of psychologizing myalgic encephalomyelitis and post-acute infection syndromes. Cover art by Jem Yoshioka.

Mar 18 •

Janna Moen, PhD

November 2023

The convoluted role of serotonin in infection-associated chronic illness

Could deficits in serotonin signaling explain cognitive dysfunction following viral infections?

Nov 16, 2023 •

Janna Moen, PhD

May 2023

What the data actually say about COVID-19 and neurodegeneration

No, SARS-CoV-2 is not a prion disease... but it can damage your nervous system.

May 25, 2023 •

Janna Moen, PhD

April 2023

Lessons from low-dose naltrexone as a glial modulator to treat neuroinflammation

Is reducing the activation of microglia a viable treatment strategy for long COVID and myalgic encephalomyelitis?

Apr 19, 2023 •

Janna Moen, PhD

February 2023

Deep dive: microclots in long COVID

Could persistent miniature blood clots drive long COVID symptoms?

Feb 19, 2023 •

Janna Moen, PhD

November 2022

September 2022

This is the Long COVID Research Breakdown, a newsletter taking the latest long COVID breakthroughs and making them easier to understand.

Sep 1, 2022 •

Janna Moen, PhD

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts